-
Je něco špatně v tomto záznamu ?
Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells
J. Carvalho, A. Paiva, MP. Cabral Campello, A. Paulo, JL. Mergny, GF. Salgado, JA. Queiroz, C. Cruz,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01 do 2019-12-31
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01 do 2019-12-31
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
Springer Nature - nature.com Journals - Fully Open Access
od 2011-12-01
- MeSH
- aptamery nukleotidové metabolismus farmakologie MeSH
- buněčné linie MeSH
- buňky A549 MeSH
- fibroblasty cytologie účinky léků metabolismus MeSH
- fosfoproteiny antagonisté a inhibitory genetika metabolismus MeSH
- G-kvadruplexy * MeSH
- genetická transkripce MeSH
- HeLa buňky MeSH
- lidé MeSH
- ligandy MeSH
- nádorové buněčné linie MeSH
- oligodeoxyribonukleotidy metabolismus farmakologie MeSH
- orgánová specificita MeSH
- promotorové oblasti (genetika) MeSH
- proteiny vázající RNA antagonisté a inhibitory genetika metabolismus MeSH
- protinádorové látky metabolismus farmakologie MeSH
- protoonkogenní proteiny c-myc genetika metabolismus MeSH
- regulace genové exprese u nádorů * MeSH
- technika přenosu genů MeSH
- vazba proteinů MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
AS1411 is a G-rich DNA oligonucleotide that functions as an aptamer of the protein nucleolin, found at high levels on the surface of cancer cells but not on the surface of normal cells. Herein, we have studied AS1411 as a supramolecular carrier for the delivery of an acridine-based G-quadruplex ligand, C8, to HeLa cancer cells. Two AS1411 derivatives, LNA-AS1411 and U-AS1411, were also tested, in an attempt to compare AS1411 pharmacological properties. The results showed that AS1411-C8 complexation was made with great binding strength and that it lowered the ligand's cytotoxicity towards non-malignant cells. This effect was suggested to be due to a decreased internalization of the complexed versus free C8 as shown by flow cytometry. The AS1411 derivatives, despite forming a stable complex with C8, lacked the necessary tumour-selective behaviour. The binding of C8 to AS1411 G-quadruplex structure did not negatively affect the recognition of nucleolin by the aptamer. The AS1411-C8 repressed c-MYC expression at the transcriptional level, possibly due to C8 ability to stabilize the c-MYC promoter G-quadruplexes. Overall, this study demonstrates the usefulness of AS1411 as a supramolecular carrier of the G-quadruplex binder C8 and the potential of using its tumour-selective properties for the delivery of ligands for cancer therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028901
- 003
- CZ-PrNML
- 005
- 20210114155313.0
- 007
- ta
- 008
- 210105s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-019-44388-9 $2 doi
- 035 __
- $a (PubMed)31138870
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Carvalho, Josué $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal.
- 245 10
- $a Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells / $c J. Carvalho, A. Paiva, MP. Cabral Campello, A. Paulo, JL. Mergny, GF. Salgado, JA. Queiroz, C. Cruz,
- 520 9_
- $a AS1411 is a G-rich DNA oligonucleotide that functions as an aptamer of the protein nucleolin, found at high levels on the surface of cancer cells but not on the surface of normal cells. Herein, we have studied AS1411 as a supramolecular carrier for the delivery of an acridine-based G-quadruplex ligand, C8, to HeLa cancer cells. Two AS1411 derivatives, LNA-AS1411 and U-AS1411, were also tested, in an attempt to compare AS1411 pharmacological properties. The results showed that AS1411-C8 complexation was made with great binding strength and that it lowered the ligand's cytotoxicity towards non-malignant cells. This effect was suggested to be due to a decreased internalization of the complexed versus free C8 as shown by flow cytometry. The AS1411 derivatives, despite forming a stable complex with C8, lacked the necessary tumour-selective behaviour. The binding of C8 to AS1411 G-quadruplex structure did not negatively affect the recognition of nucleolin by the aptamer. The AS1411-C8 repressed c-MYC expression at the transcriptional level, possibly due to C8 ability to stabilize the c-MYC promoter G-quadruplexes. Overall, this study demonstrates the usefulness of AS1411 as a supramolecular carrier of the G-quadruplex binder C8 and the potential of using its tumour-selective properties for the delivery of ligands for cancer therapy.
- 650 _2
- $a buňky A549 $7 D000072283
- 650 _2
- $a protinádorové látky $x metabolismus $x farmakologie $7 D000970
- 650 _2
- $a aptamery nukleotidové $x metabolismus $x farmakologie $7 D052157
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a fibroblasty $x cytologie $x účinky léků $x metabolismus $7 D005347
- 650 12
- $a G-kvadruplexy $7 D054856
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a technika přenosu genů $7 D018014
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a oligodeoxyribonukleotidy $x metabolismus $x farmakologie $7 D009838
- 650 _2
- $a orgánová specificita $7 D009928
- 650 _2
- $a fosfoproteiny $x antagonisté a inhibitory $x genetika $x metabolismus $7 D010750
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a protoonkogenní proteiny c-myc $x genetika $x metabolismus $7 D016271
- 650 _2
- $a proteiny vázající RNA $x antagonisté a inhibitory $x genetika $x metabolismus $7 D016601
- 650 _2
- $a genetická transkripce $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Paiva, Artur $u Unidade de Gestão Operacional em Citometria, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal. CIMAGO/iCBR/CIBB, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal. Instituto Politécnico de Coimbra, ESTESC-Coimbra Health School, Ciências Biomédicas Laboratoriais, Coimbra, Portugal.
- 700 1_
- $a Cabral Campello, Maria Paula $u Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10 (km 139,7), 2695-066, Bobadela, LRS, Portugal.
- 700 1_
- $a Paulo, António $u Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10 (km 139,7), 2695-066, Bobadela, LRS, Portugal.
- 700 1_
- $a Mergny, Jean-Louis $u Univ. Bordeaux, ARNA laboratory, INSERM, U1212, CNRS UMR 5320, IECB, F-33600, Pessac, France. Institute of Biophysics, AS CR, v.v.i. Kralovopolska 135, 612 65, Brno, Czech Republic.
- 700 1_
- $a Salgado, Gilmar F $u Univ. Bordeaux, ARNA laboratory, INSERM, U1212, CNRS UMR 5320, IECB, F-33600, Pessac, France.
- 700 1_
- $a Queiroz, João A $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal.
- 700 1_
- $a Cruz, Carla $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal. carlacruz@fcsaude.ubi.pt.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 7945
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31138870 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114155311 $b ABA008
- 999 __
- $a ok $b bmc $g 1609236 $s 1120081
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c 1 $d 7945 $e 20190528 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210105